These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 36669358)
1. Antibiotic resistance and drug modification: Synthesis, characterization and bioactivity of newly modified potent pleuromutilin derivatives with a substituted piperazine moiety. Yi Y; Yang S; Liu Y; Yin B; Zhao Z; Li G; Huang Z; Chen L; Liu F; Shang R; Lin S Bioorg Chem; 2023 Mar; 132():106353. PubMed ID: 36669358 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety. Yi Y; Xu X; Liu Y; Xu S; Huang X; Liang J; Shang R Eur J Med Chem; 2017 Jan; 126():687-695. PubMed ID: 27940400 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel pleuromutilin derivatives as potent antibacterial agents. Zhou Y; Yi Y; Wang J; Yang Z; Liu Q; Pu W; Shang R Eur J Med Chem; 2022 Jul; 237():114403. PubMed ID: 35472849 [TBL] [Abstract][Full Text] [Related]
4. Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation. Fan Y; Liu Y; Wang H; Shi T; Cheng F; Hao B; Yi Y; Shang R Eur J Med Chem; 2020 Dec; 207():112735. PubMed ID: 32827940 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vitro and in vivo evaluation and molecular docking study of novel pleuromutilin derivatives as antibacterial agents. Liu J; Ren J; Zuo XY; Zhou KX; Tang YZ; Jin Z Fitoterapia; 2024 Jul; 176():106046. PubMed ID: 38821322 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker. Zhang GY; Zhang Z; Li K; Liu J; Li B; Jin Z; Liu YH; Tang YZ Bioorg Chem; 2020 Dec; 105():104398. PubMed ID: 33137559 [TBL] [Abstract][Full Text] [Related]
7. Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit. Wang X; Wang R; Zhang ZS; Zhang GY; Jin Z; Shen R; Du D; Tang YZ Eur J Med Chem; 2022 Jul; 237():114341. PubMed ID: 35430480 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives. Yi Y; Fu Y; Dong P; Qin W; Liu Y; Liang J; Shang R Molecules; 2017 Jun; 22(6):. PubMed ID: 28617344 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents. Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1 Wang J; Hu YH; Zhou KX; Wang W; Li F; Li K; Zhang GY; Tang YZ Molecules; 2023 May; 28(9):. PubMed ID: 37175382 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives. Ates-Alagoz Z; Kisla MM; Goker H; Yildiz S Med Chem; 2021; 17(7):699-706. PubMed ID: 32310051 [TBL] [Abstract][Full Text] [Related]
12. Chemical synthesis and biological activities of novel pleuromutilin derivatives with substituted amino moiety. Shang R; Wang S; Xu X; Yi Y; Guo W; Yuliu ; Liang J PLoS One; 2013; 8(12):e82595. PubMed ID: 24376551 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents. Zhang QW; Ren J; Lu JX; Chen XY; He XJ; Wang Q; Zhou ZD; Jin Z; Zeng ZL; Tang YZ Drug Dev Res; 2023 Nov; 84(7):1437-1452. PubMed ID: 37534779 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker. Zhang ZS; Huang YZ; Luo J; Wang BF; Jin Z; Liu YH; Tang YZ Med Chem; 2018; 14(6):585-594. PubMed ID: 29663895 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker. Jin Z; Wang L; Gao H; Zhou YH; Liu YH; Tang YZ Eur J Med Chem; 2019 Nov; 181():111594. PubMed ID: 31419741 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of novel pleuromutilin derivatives with a substituted thiadiazole moiety as potent drug-resistant bacteria inhibitors. Shang R; Pu X; Xu X; Xin Z; Zhang C; Guo W; Liu Y; Liang J J Med Chem; 2014 Jul; 57(13):5664-78. PubMed ID: 24892980 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel pleuromutilin derivatives with a substituted pyrimidine moiety. Yi Y; Yang G; Zhang C; Chen J; Liang J; Shang R Eur J Med Chem; 2015 Aug; 101():179-84. PubMed ID: 26134552 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo. Li B; Zhang Z; Zhang JF; Liu J; Zuo XY; Chen F; Zhang GY; Fang HQ; Jin Z; Tang YZ Eur J Med Chem; 2021 Nov; 223():113624. PubMed ID: 34153574 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety. Zhang ZS; Huang YZ; Luo J; Jin Z; Liu YH; Tang YZ Chem Biol Drug Des; 2018 Sep; 92(3):1627-1637. PubMed ID: 29722184 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker. Gao ML; Zeng J; Fang X; Luo J; Jin Z; Liu YH; Tang YZ Eur J Med Chem; 2017 Feb; 127():286-295. PubMed ID: 28068600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]